Photo of Nagla Abdel Karim from netrf.org
Jun 13, 2024, 13:11
Nagla Abdel Karim: It is such a great honor to be selected to chair the oligometastatic subgroup
Nagla Abdel Karim, Director of the Phase I Program at Inova Schar Cancer Institute, shared on X:
“It is such a great honor to be selected to chair the oligometastatic subgroup.”
Source: Nagla Abdel Karim/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56
Nov 13, 2024, 15:46
Nov 13, 2024, 15:32
Nov 13, 2024, 15:29